BGM Group Ltd. Class A Ordinary Shares

BGM XNAS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

120M

Short interest (Jul 15)

0.1%

Net Short (Jul 27 ): 0.0%

Borrow Fee

5.15%

↑ 8.3%

Available Shares

900K

↑ 4.7%

Price Chart

Company Overview

BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.

Company Info

Exchange: NASDAQ

CIK: 0001779578

Asset Type: CS

Market Data

Market Cap: $116,060,586

Employees: 471

Status: Active

Short Interest

Current Borrow Fee 5.15%

Range: 5.15% - 5.78%

Available Shares 900K

Range: 900K - 1M

Recent Changes

Fee Change: ↑ 0.3%

Available Change: ↓ 0.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime